Abstract:During infection, the fusion peptide (FP) of HIV envelope glycoprotein (Env) serves a central role in viral fusion with the host cell. As such, the FP is highly conserved and therefore an attractive epitope for vaccine design. Here, we describe a vaccination study in non-human primates (NHPs) where glycan deletions were made on soluble HIV Env to increase FP epitope exposure. When delivered via implantable osmotic pumps, this immunogen primed immune responses against the FP, which were then boosted with heterologous trimers resulting in a focused immune response targeting the conserved FP epitope. Although autologous immunizations did not elicit high affinity FP-targeting antibodies, the conserved FP epitope on a heterologous trimer further matured the lower affinity, FP-targeting B cells. This study suggests using epitope conservation strategies on distinct Env trimer immunogens can focus humoral responses on desired neutralizing epitopes and suppress immune-distracting antibody responses against non-neutralizing epitopes.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to induce a high - titer antibody response against the fusion peptide (FP) of the HIV envelope glycoprotein (Env) through specific immune - focusing strategies in HIV vaccine design. Specifically, the researchers hope to increase the exposure of the fusion peptide epitope by deleting specific N - linked glycosylation sites, thereby guiding non - human primates (NHPs) to generate an immune response against this conserved region. The paper describes a vaccine study in non - human primates, in which soluble HIV Env was used as an immunogen and delivered through an implantable osmotic pump in an attempt to trigger an immune response against the fusion peptide. Subsequently, through heterotrimeric booster immunizations, it further focuses on the conserved fusion peptide epitope in an attempt to mature low - affinity FP - targeting B cells. The main objectives of the study include: 1. **Increase the exposure of the fusion peptide epitope**: By deleting specific N - linked glycosylation sites, make the fusion peptide epitope more easily recognized by the immune system. 2. **Induce efficient FP - targeting antibodies**: Through heterotrimeric booster immunizations, further mature low - affinity FP - targeting B cells, thereby generating high - affinity neutralizing antibodies. 3. **Evaluate the effectiveness of the immune - focusing strategy**: Through a variety of experimental methods (such as negative - stain electron microscopy polyclonal epitope mapping/nsEMPEM, cryo - electron microscopy polyclonal epitope mapping/cryoEMPEM, etc.), evaluate whether the immune - focusing strategy can effectively guide the immune response to concentrate on the desired neutralizing epitope while suppressing the immune response to non - neutralizing epitopes. Overall, this study aims to explore how to improve the effectiveness of HIV vaccine design through precise immune - focusing strategies, especially in inducing broadly neutralizing antibodies.

Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques